Organ support & nutrition

Plasma endostatin and its association with new-onset acute kidney injury in critical care

J Intensive CarePublished Retrospective multicentre cohort study

Authors' conclusion

Endostatin at ICU admission is an independent predictor of new-onset AKI and may improve early AKI risk assessment in the ICU. However, its predictive value for RRT and 30-day mortality appears limited.

Study context

Population
Intensive care unit (ICU) admissions to four ICUs
Participants
4,732 admissions
Exposure
Plasma endostatin at ICU admission vs creatinine and cystatin C as predictors
Outcome
New-onset AKI (KDIGO criteria)
Follow-up
Within 48 h after ICU admission
Methodological details4 ICUs, prospectively obtained samples, retrospectively analysed, repeated cross-validation
  • 4 ICUs
  • Prospectively obtained samples, retrospectively analysed
  • Repeated cross-validation

Main finding

As reported in the abstract

New-onset AKI
Odds ratio (95% CI)
Endostatinindependent of creatinine, cystatin C, and SAPS-3
1.7(1.5–1.9)
Endostatin vs Creatinine and cystatin C · endostatin superior
mean AUC 0.67 vs. 0.63; P < 0.001

Observational data: associations, not effects.

Further findings

New-onset stage 3 acute kidney injury (AKI)

OR (95% CI)
EndostatinIndependent of creatinine, cystatin C, and SAPS-31.4 (1.2–1.6)

Renal replacement therapy (RRT) · within 7 days after ICU admission

OR (95% CI)
EndostatinIndependent of creatinine, cystatin C, and SAPS-31.2 (1.05–1.4)

New-onset stage 3 AKI

Adding endostatin to creatinine improved prediction of new-onset stage 3 AKI

RRT · within 7 days after ICU admission

Adding endostatin to creatinine did not improve prediction of need for RRT

30-day mortality

Endostatin not associated with 30-day mortality after adjusting for SAPS-3

Original publication

Plasma endostatin and its association with new-onset acute kidney injury in critical care. J Intensive Care. Published 2 September 2025. doi:10.1186/s40560-025-00820-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.